Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
Subcutaneous nivolumab is also under review in the United States based on findings from the phase 3 CheckMate-67T trial.
Lipid droplet formation is a prominent histological feature in clear cell renal cell carcinoma (ccRCC), but the significance and mechanisms underlying lipid droplet accumulation remain unclear. Expression and clinical significance of MT1G in ccRCC were analyzed by using TCGA data, GEO data and ...
The European Medicines Agency will begin a centralized review process for subcutaneous nivolumab across multiple solid tumor indications.
The liver is the fourth most common site of metastasis in renal cell carcinoma (RCC), which is usually treated with systemic therapies and local treatments. ...
Focusing on renal cell carcinoma, the Oncology Brothers and Toni Choueiri, MD, discuss KIM-1, a biomarker analysis in IMmotion010.
Michael Serzan, MD, discusses what a community oncologist should know about the phase 2 ARCITECT trial for patients with clear cell renal cell carcinoma.
A minimally invasive cryoablation technology system designed to treat patients with kidney tumors and elicit an 89.65% recurrence-free rate.
Differentiating between health concerns becomes a challenge even for the most experienced medical professionals when two different illnesses exhibit similar symptoms. One such case involves kidney cancer and kidney stones. As we observe World Kidney Cancer Day on 20th June this year, let's ...
According to Globocan 2022 estimates, in India, there were about 17,000 new cases of kidney cancer and 10,000 deaths attributed to the disease during 2021-22. Statistics show that in India, approximately 1 in 442 men and 1 in 600 women are at risk of developing kidney cancer. It's observed ...
(Pembrolizumab + vibostolimab) is under clinical development by Merck and currently in Phase II for Metastatic Renal Cell Carcinoma.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.